Kairos Pharma

Los Angeles, United States

Kairos Pharma is a clinical-stage biopharmaceutical company focused on cancer immunotherapy and drug resistance.

$75.0M raised

Jan 2026

Post-IPO Equity

Biotechnology Pharmaceutical Therapeutics

Top Investors

U.S. Department of War Congressionally Directed Medical Research Programs

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Kairos Pharma

How much funding has Kairos Pharma raised?

Kairos Pharma has raised $75.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2026.

Who are Kairos Pharma's investors?

Kairos Pharma's investors include U.S. Department of War, Congressionally Directed Medical Research Programs.

Where is Kairos Pharma headquartered?

Kairos Pharma is headquartered in Los Angeles, United States.

What does Kairos Pharma do?

Kairos Pharma is a clinical-stage biopharmaceutical company focused on cancer immunotherapy and drug resistance.

What stage is Kairos Pharma at?

Kairos Pharma is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 12, 2026.

MLA

"Kairos Pharma — Funding & Investors." VCBacked, January 12, 2026, https://www.vcbacked.co/company/kairos-pharma. Accessed July 2, 2026.

APA

VCBacked. (2026). Kairos Pharma — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/kairos-pharma

Wikipedia (cite web)

{{cite web |title=Kairos Pharma — Funding & Investors |url=https://www.vcbacked.co/company/kairos-pharma |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 12, 2026.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K